miR-126 contributes to the epigenetic signature of diabetic vascular smooth muscle and enhances antirestenosis effects of Kv1.3 blockers

• Главные авторы: Marycarmen Arevalo-Martinez (Автор), Pilar Cidad (Автор), Sara Moreno-Estar (Автор), Mirella Fernández (Автор), Sebastian Albinsson (Автор), Irene Cózar-Castellano (Автор), José R. López-López (Автор), M. Teresa Pérez-Garcia (Автор)
• Формат: ‌
• Опубликовано: Elsevier, 2021-11-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Objectives: Restenosis after vessel angioplasty due to dedifferentiation of the vascular smooth muscle cells (VSMCs) limits the success of surgical treatment of vascular occlusions. Type 2 diabetes (T2DM) has a major impact on restenosis, with patients exhibiting more aggressive forms of vascular di...